Showing 1 - 10 of 5,417
Persistent link: https://www.econbiz.de/10003931919
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10009659550
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10014195216
Persistent link: https://www.econbiz.de/10008649175
Persistent link: https://www.econbiz.de/10008649176
Persistent link: https://www.econbiz.de/10002417252
Persistent link: https://www.econbiz.de/10000613160
Persistent link: https://www.econbiz.de/10001461562
Persistent link: https://www.econbiz.de/10003863791
Persistent link: https://www.econbiz.de/10011785457